Diagnostic benefit of the detection of autoantibodies against intrinsic factor
They advised the panel to vote no
A 2006 Achilles-detachment study by Krivic and colleagues in the same journal applied BPC-157 intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg for 30 days in rats and reported that tendon-to-bone tissue, which did not heal spontaneously in saline controls, recovered with BPC-157 treatment, with directionally improved load-to-failure, stiffness, Young's modulus, and collagen organization at days 121, including in animals where healing had been impaired by 1 mg/kg 6-methylprednisolone though the abstract does not report numeric effect sizes or p-values
Get started today
Closing: The Technique Is Part of the Protocol Peptide therapy outcomes depend on two equal pillars: the quality of the peptide and the consistency of the administration
Case Series and Pilot Studies: In recent years, a few small-scale human studies have surfaced, often by clinicians using BPC-157 in practice and then writing up their observations
